UNLABELLED: Foreign-born individuals comprise the majority of patients treated for latent tuberculosis infection (LTBI) in the US. It is important to understand this population's tuberculosis-related knowledge, attitudes, and beliefs (KAB) as they may affect treatment acceptance and completion. KAB in 84 US-born and 167 foreign-born LTBI patients enrolled in a clinical trial assessing treatment completion at an urban public hospital were assessed at baseline. Demographic and substance use information was also collected. RESULTS: Of 251 participants, 66.5% were foreign-born. While misconceptions existed among both US and foreign-born regarding transmission and contagiousness of LTBI, overall knowledge scores did not differ significantly between groups. With respect to attitudinal factors, foreign-born participants were less likely to acknowledge that they had LTBI and felt more "protected" from developing TB. Improved understanding of foreign-born patients' KAB may contribute to the reduction of barriers to treatment and improved outcomes.
UNLABELLED: Foreign-born individuals comprise the majority of patients treated for latent tuberculosis infection (LTBI) in the US. It is important to understand this population's tuberculosis-related knowledge, attitudes, and beliefs (KAB) as they may affect treatment acceptance and completion. KAB in 84 US-born and 167 foreign-born LTBIpatients enrolled in a clinical trial assessing treatment completion at an urban public hospital were assessed at baseline. Demographic and substance use information was also collected. RESULTS: Of 251 participants, 66.5% were foreign-born. While misconceptions existed among both US and foreign-born regarding transmission and contagiousness of LTBI, overall knowledge scores did not differ significantly between groups. With respect to attitudinal factors, foreign-born participants were less likely to acknowledge that they had LTBI and felt more "protected" from developing TB. Improved understanding of foreign-born patients' KAB may contribute to the reduction of barriers to treatment and improved outcomes.
Authors: Elvin Geng; Barry Kreiswirth; Cynthia Driver; Jiehui Li; Joseph Burzynski; Phyllis DellaLatta; Angel LaPaz; Neil W Schluger Journal: N Engl J Med Date: 2002-05-09 Impact factor: 91.245
Authors: Salla A Munro; Simon A Lewin; Helen J Smith; Mark E Engel; Atle Fretheim; Jimmy Volmink Journal: PLoS Med Date: 2007-07-24 Impact factor: 11.069
Authors: Jamie P Morano; Alexei Zelenev; Mary R Walton; R Douglas Bruce; Frederick L Altice Journal: Am J Public Health Date: 2014-06-12 Impact factor: 9.308
Authors: Meredith M Howley; Chaturia D Rouse; Dolores J Katz; Paul W Colson; Yael Hirsch-Moverman; Rachel A Royce Journal: J Immigr Minor Health Date: 2015-10
Authors: Paul W Colson; G Lance Couzens; Rachel A Royce; Tracy Kline; Tamara Chavez-Lindell; Sharon Welbel; Jenny Pang; Amy Davidow; Yael Hirsch-Moverman Journal: J Immigr Minor Health Date: 2014-02